Literature DB >> 23013229

Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ₁ receptor ligands.

Jens Köhler1, Klaus Bergander, Jörg Fabian, Dirk Schepmann, Bernhard Wünsch.   

Abstract

We synthesized and investigated the NMDA and σ₁ receptor affinity of enantiomerically pure 2-(2-phenyl-1,3-dioxan-4-yl)ethanamines 17-26. The primary amines (R,R)-18-20 with an axially oriented phenyl moiety in position 2 interacted with high enantioselectivity (eudismic ratios 70-130) and high affinity (K(i)((R,R)-19) = 13 nM) with the PCP binding site of the NMDA receptor. Introduction of an N-benzyl moiety led to potent σ₁ ligands including compound (S,R)-22 (K(i) = 6 nM) with an equatorially oriented phenyl moiety in position 2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013229     DOI: 10.1021/jm301166m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells.

Authors:  Maria Beatrice Morelli; Consuelo Amantini; Massimo Nabissi; Giorgio Santoni; Bernhard Wünsch; Dirk Schepmann; Cristina Cimarelli; Maura Pellei; Carlo Santini; Stefano Fontana; Valerio Mammoli; Wilma Quaglia; Alessandro Bonifazi; Mario Giannella; Gianfabio Giorgioni; Alessandro Piergentili; Fabio Del Bello
Journal:  ACS Med Chem Lett       Date:  2019-01-28       Impact factor: 4.345

2.  Do GluN2B subunit containing NMDA receptors tolerate a fluorine atom in the phenylalkyl side chain?

Authors:  Yoshihiro Shuto; Simone Thum; Louisa Temme; Dirk Schepmann; Masato Kitamura; Bernhard Wünsch
Journal:  Medchemcomm       Date:  2017-03-17       Impact factor: 3.597

3.  Synthesis of Aminoethyl-Substituted Piperidine Derivatives as σ1 Receptor Ligands with Antiproliferative Properties.

Authors:  Catharina Holtschulte; Frederik Börgel; Stefanie Westphälinger; Dirk Schepmann; Gianluca Civenni; Erik Laurini; Domenico Marson; Carlo V Catapano; Sabrina Pricl; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2022-02-09       Impact factor: 3.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.